Tech Company Financing Transactions
Silvergate Pharmaceuticals Funding Round
On 6/17/2013, Silvergate Pharmaceuticals announced $23.6 million in financing from Frazier Healthcare Partners and private investors.
Transaction Overview
Company Name
Announced On
6/17/2013
Transaction Type
Venture Equity
Amount
$23,554,167
Round
Undisclosed
Investors
Frazier Healthcare Partners (Nathan Every)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6251 Greenwood Plaza Blvd. 101
Greenwood Village, CO 80111
USA
Greenwood Village, CO 80111
USA
Phone
Website
Email Address
Overview
The company is developing technologies that reformulate adult pharmaceuticals for the pediatric market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank Segrave
Chief Financial Officer
Barry Barnard
VP - Bus. Development
Michael Beckloff
Browse more venture capital transactions:
Prev: 6/17/2013: Minimally Invasive Devices venture capital transaction
Next: 6/17/2013: Viamet Pharmaceuticals venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs